Global Bispecific Antibody Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries

Global Bispecific Antibody Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries

Reports Details

The Global market for Bispecific Antibody is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach USD X.X million in 2027, from USD X.X million in 2020.

Aimed to provide most segmented consumption and sales data of different types of Bispecific Antibody, downstream consumption fields and competitive landscape in different regions and countries around the world, this report analyzes the latest market data from the primary and secondary authoritative source.

The report also tracks the latest market dynamics, such as driving factors, restraining factors, and industry news like mergers, acquisitions, and investments. It provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries.

The report can help to understand the market and strategize for business expansion accordingly. In the strategy analysis, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the Bispecific Antibody industry.

The report focuses on the top players in terms of profiles, product analysis, sales, price, revenue, and gross margin.
Major players covered in this report:
Eli Lilly
Chugai Pharmaceutical
Roche
EMD Serono
MacroGenics
AstraZeneca (MedImmune)
Sanofi
Neovii Biotech
Genmab
Affimed Therapeutics
Jounce Therapeutics
Genentech
Regeneron Pharmaceuticals
Pieris
Emergent BioSolutions
OncoMed Pharmaceuticals
Immunomedics
Ablynx
Amgen
Merus
NovImmune SA
Adimab

By Type:
Catumaxomab (Removab)
Blinatumomab
Duligotumab
SAR 156597

By Application:
BsMAb for Diagnosis of Infectious Diseases
Diagnosis of Bacterial Infections
Diagnosis of Viral Infections
BsMAb for Cancer Diagnostic
BsAbs Blocking Signaling Pathways
BsAbs Targeting Tumor Angiogenesis
Specific Delivery of Effector Compounds to Targets
Bispecific Antibodies & Gene Therapy

Geographically, the regional consumption and value analysis by types, applications, and countries are included in the report. Furthermore, it also introduces the major competitive players in these regions.
Major regions covered in the report:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

Country-level segmentation in the report:
United States
Germany
UK
France
Italy
Spain
Poland
Russia
China
Japan
India
Indonesia
Thailand
Philippines
Malaysia
Singapore
Vietnam
Brazil
Saudi Arabia
United Arab Emirates
Qatar
Bahrain

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Table of Content

1 Market Overview
1.1 Bispecific Antibody Introduction
1.2 Market Analysis by Type
1.2.1 Catumaxomab (Removab)
1.2.2 Blinatumomab
1.2.3 Duligotumab
1.2.4 SAR 156597
1.3 Market Analysis by Application
1.3.1 BsMAb for Diagnosis of Infectious Diseases
1.3.2 Diagnosis of Bacterial Infections
1.3.3 Diagnosis of Viral Infections
1.3.4 BsMAb for Cancer Diagnostic
1.3.5 BsAbs Blocking Signaling Pathways
1.3.6 BsAbs Targeting Tumor Angiogenesis
1.3.7 Specific Delivery of Effector Compounds to Targets
1.3.8 Bispecific Antibodies & Gene Therapy
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2015-2027)
1.4.2 Europe Market States and Outlook (2015-2027)
1.4.3 China Market States and Outlook (2015-2027)
1.4.4 Japan Market States and Outlook (2015-2027)
1.4.5 Southeast Asia Market States and Outlook (2015-2027)
1.4.6 India Market States and Outlook (2015-2027)
1.4.7 Brazil Market States and Outlook (2015-2027)
1.4.8 GCC Countries Market States and Outlook (2015-2027)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global Bispecific Antibody Market Size Analysis from 2015 to 2027
1.6.1 Global Bispecific Antibody Market Size Analysis from 2015 to 2027 by Consumption Volume
1.6.2 Global Bispecific Antibody Market Size Analysis from 2015 to 2027 by Value
1.6.3 Global Bispecific Antibody Price Trends Analysis from 2015 to 2027

2 Global Bispecific Antibody Competition by Types, Applications, and Top Regions and Countries
2.1 Global Bispecific Antibody (Volume and Value) by Type
2.1.1 Global Bispecific Antibody Consumption and Market Share by Type (2015-2020)
2.1.2 Global Bispecific Antibody Revenue and Market Share by Type (2015-2020)
2.2 Global Bispecific Antibody (Volume and Value) by Application
2.2.1 Global Bispecific Antibody Consumption and Market Share by Application (2015-2020)
2.2.2 Global Bispecific Antibody Revenue and Market Share by Application (2015-2020)
2.3 Global Bispecific Antibody (Volume and Value) by Region
2.3.1 Global Bispecific Antibody Consumption and Market Share by Region (2015-2020)
2.3.2 Global Bispecific Antibody Revenue and Market Share by Region (2015-2020)

3 United States Bispecific Antibody Market Analysis
3.1 United States Bispecific Antibody Consumption and Value Analysis
3.2 United States Bispecific Antibody Consumption Volume by Type
3.3 United States Bispecific Antibody Consumption Structure by Application

4 Europe Bispecific Antibody Market Analysis
4.1 Europe Bispecific Antibody Consumption and Value Analysis
4.2 Europe Bispecific Antibody Consumption Volume by Type
4.3 Europe Bispecific Antibody Consumption Structure by Application
4.4 Europe Bispecific Antibody Consumption by Top Countries
4.4.1 Germany Bispecific Antibody Consumption Volume from 2015 to 2020
4.4.2 UK Bispecific Antibody Consumption Volume from 2015 to 2020
4.4.3 France Bispecific Antibody Consumption Volume from 2015 to 2020
4.4.4 Italy Bispecific Antibody Consumption Volume from 2015 to 2020
4.4.5 Spain Bispecific Antibody Consumption Volume from 2015 to 2020
4.4.6 Poland Bispecific Antibody Consumption Volume from 2015 to 2020
4.4.7 Russia Bispecific Antibody Consumption Volume from 2015 to 2020

5 China Bispecific Antibody Market Analysis
5.1 China Bispecific Antibody Consumption and Value Analysis
5.2 China Bispecific Antibody Consumption Volume by Type
5.3 China Bispecific Antibody Consumption Structure by Application

6 Japan Bispecific Antibody Market Analysis
6.1 Japan Bispecific Antibody Consumption and Value Analysis
6.2 Japan Bispecific Antibody Consumption Volume by Type
6.3 Japan Bispecific Antibody Consumption Structure by Application

7 Southeast Asia Bispecific Antibody Market Analysis
7.1 Southeast Asia Bispecific Antibody Consumption and Value Analysis
7.2 Southeast Asia Bispecific Antibody Consumption Volume by Type
7.3 Southeast Asia Bispecific Antibody Consumption Structure by Application
7.4 Southeast Asia Bispecific Antibody Consumption by Top Countries
7.4.1 Indonesia Bispecific Antibody Consumption Volume from 2015 to 2020
7.4.2 Thailand Bispecific Antibody Consumption Volume from 2015 to 2020
7.4.3 Philippines Bispecific Antibody Consumption Volume from 2015 to 2020
7.4.4 Malaysia Bispecific Antibody Consumption Volume from 2015 to 2020
7.4.5 Singapore Bispecific Antibody Consumption Volume from 2015 to 2020
7.4.6 Vietnam Bispecific Antibody Consumption Volume from 2015 to 2020

8 India Bispecific Antibody Market Analysis
8.1 India Bispecific Antibody Consumption and Value Analysis
8.2 India Bispecific Antibody Consumption Volume by Type
8.3 India Bispecific Antibody Consumption Structure by Application

9 Brazil Bispecific Antibody Market Analysis
9.1 Brazil Bispecific Antibody Consumption and Value Analysis
9.2 Brazil Bispecific Antibody Consumption Volume by Type
9.3 Brazil Bispecific Antibody Consumption Structure by Application

10 GCC Countries Bispecific Antibody Market Analysis
10.1 GCC Countries Bispecific Antibody Consumption and Value Analysis
10.2 GCC Countries Bispecific Antibody Consumption Volume by Type
10.3 GCC Countries Bispecific Antibody Consumption Structure by Application
10.4 GCC Countries Bispecific Antibody Consumption Volume by Major Countries
10.4.1 Saudi Arabia Bispecific Antibody Consumption Volume from 2015 to 2020
10.4.2 United Arab Emirates Bispecific Antibody Consumption Volume from 2015 to 2020
10.4.3 Qatar Bispecific Antibody Consumption Volume from 2015 to 2020
10.4.4 Bahrain Bispecific Antibody Consumption Volume from 2015 to 2020

11 Manufacturers Profiles
11.1 Eli Lilly
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 Eli Lilly Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.1.4 Eli Lilly Bispecific Antibody Sales by Region
11.2 Chugai Pharmaceutical
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 Chugai Pharmaceutical Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.2.4 Chugai Pharmaceutical Bispecific Antibody Sales by Region
11.3 Roche
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 Roche Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.3.4 Roche Bispecific Antibody Sales by Region
11.4 EMD Serono
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 EMD Serono Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.4.4 EMD Serono Bispecific Antibody Sales by Region
11.5 MacroGenics
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 MacroGenics Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.5.4 MacroGenics Bispecific Antibody Sales by Region
11.6 AstraZeneca (MedImmune)
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 AstraZeneca (MedImmune) Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.6.4 AstraZeneca (MedImmune) Bispecific Antibody Sales by Region
11.7 Sanofi
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 Sanofi Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.7.4 Sanofi Bispecific Antibody Sales by Region
11.8 Neovii Biotech
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 Neovii Biotech Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.8.4 Neovii Biotech Bispecific Antibody Sales by Region
11.9 Genmab
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 Genmab Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.9.4 Genmab Bispecific Antibody Sales by Region
11.10 Affimed Therapeutics
11.10.1 Business Overview
11.10.2 Products Analysis
11.10.3 Affimed Therapeutics Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.10.4 Affimed Therapeutics Bispecific Antibody Sales by Region
11.11 Jounce Therapeutics
11.11.1 Business Overview
11.11.2 Products Analysis
11.11.3 Jounce Therapeutics Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.11.4 Jounce Therapeutics Bispecific Antibody Sales by Region
11.12 Genentech
11.12.1 Business Overview
11.12.2 Products Analysis
11.12.3 Genentech Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.12.4 Genentech Bispecific Antibody Sales by Region
11.13 Regeneron Pharmaceuticals
11.13.1 Business Overview
11.13.2 Products Analysis
11.13.3 Regeneron Pharmaceuticals Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.13.4 Regeneron Pharmaceuticals Bispecific Antibody Sales by Region
11.14 Pieris
11.14.1 Business Overview
11.14.2 Products Analysis
11.14.3 Pieris Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.14.4 Pieris Bispecific Antibody Sales by Region
11.15 Emergent BioSolutions
11.15.1 Business Overview
11.15.2 Products Analysis
11.15.3 Emergent BioSolutions Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.15.4 Emergent BioSolutions Bispecific Antibody Sales by Region
11.16 OncoMed Pharmaceuticals
11.16.1 Business Overview
11.16.2 Products Analysis
11.16.3 OncoMed Pharmaceuticals Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.16.4 OncoMed Pharmaceuticals Bispecific Antibody Sales by Region
11.17 Immunomedics
11.17.1 Business Overview
11.17.2 Products Analysis
11.17.3 Immunomedics Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.17.4 Immunomedics Bispecific Antibody Sales by Region
11.18 Ablynx
11.18.1 Business Overview
11.18.2 Products Analysis
11.18.3 Ablynx Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.18.4 Ablynx Bispecific Antibody Sales by Region
11.19 Amgen
11.19.1 Business Overview
11.19.2 Products Analysis
11.19.3 Amgen Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.19.4 Amgen Bispecific Antibody Sales by Region
11.20 Merus
11.20.1 Business Overview
11.20.2 Products Analysis
11.20.3 Merus Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.20.4 Merus Bispecific Antibody Sales by Region
11.21 NovImmune SA
11.21.1 Business Overview
11.21.2 Products Analysis
11.21.3 NovImmune SA Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.21.4 NovImmune SA Bispecific Antibody Sales by Region
11.22 Adimab
11.22.1 Business Overview
11.22.2 Products Analysis
11.22.3 Adimab Bispecific Antibody Sales, Price, Revenue, Gross Margin
11.22.4 Adimab Bispecific Antibody Sales by Region

12 Marketing Strategy Analysis
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Global Bispecific Antibody Market Forecast (2020-2027)
13.1 Global Bispecific Antibody Consumption Volume, Revenue and Price Forecast (2020-2027)
13.1.1 Global Bispecific Antibody Consumption Volume and Growth Rate Forecast (2020-2027)
13.1.2 Global Bispecific Antibody Value and Growth Rate Forecast (2020-2027)
13.1.3 Global Bispecific Antibody Price and Trend Forecast (2020-2027)
13.2 Global Bispecific Antibody Consumption Volume, Value and Growth Rate Forecast by Region (2020-2027)
13.2.1 Global Bispecific Antibody Consumption Volume and Growth Rate Forecast by Region (2020-2027)
13.2.2 Global Bispecific Antibody Value and Growth Rate Forecast by Region (2020-2027)
13.3 Global Bispecific Antibody Consumption Volume, Revenue and Price Forecast by Type (2020-2027)
13.3.1 Global Bispecific Antibody Consumption Forecast by Type (2020-2027)
13.3.2 Global Bispecific Antibody Revenue Forecast by Type (2020-2027)
13.3.3 Global Bispecific Antibody Price Forecast by Type (2020-2027)
13.4 Global Bispecific Antibody Consumption Volume Forecast by Application (2020-2027)

14 Research Conclusions

15 Appendix
15.1 Methodology
15.2 Research Data Source

Request Sample



captcha




$3,960.00$5,200.00

Clear
About this Report
SKU: C2039 Category:
Share this report

About ReportsCheck

ReportsCheck is a one-stop platform that offers market research and business consulting services to various industries located globally. The market intelligence data is offered to all micro, medium and top-tier companies. We offer premium statistical analysis, global, regional and country-level reports with forecast data for companies across the globe.

Copyright © 2019, ReportsCheck – Market Research Reports. All Rights reserved.

Powered by ReportsCheck